Livongo, the leading Applied Health Signals company, today announced the Livongo for Diabetes program will now leverage Amazon Alexa's voice service to offer its Members the ability to ask any of their Alexa-enabled devices to provide their blood glucose readings and health tips via the new Livongo skill. The integration marks Livongo as the first consumer digital health company to collaborate with Amazon Alexa on a new HIPAA-compliant healthcare skill, which builds on Livongo's efforts to make
Read More
CDC Recognizes Lark Health’s A.I. Diabetes Prevention Program
Lark Health, a chronic disease prevention platform, today announced that its AI-based Diabetes Prevention Program (DPP) has received Full Recognition status from the Centers for Disease Control and Prevention. CDC Full Recognition is the highest level of clinical recognition for the DPP, and Lark is now the only DPP that uses cutting edge A.I. to be awarded this recognition.Lark's DPP is the second-largest in the country and one of the fastest-growing. Lark's A.I. platform is augmented by
Read More
Glooko Launches Integration with Novo Nordisk Insulin Pen
Today, Glooko announced the launch of their integration with the Novo Nordisk connected insulin pen on our diasend® platform and the release of their Annual Diabetes Report. With diasend, doctors were able to see and advise patients based on recorded insulin dose data from connected Novo Nordisk pens without having to invest additional time. Now, to raise the bar for patient convenience even further, Glooko is launching the ability to also upload pen data remotely – straight from any near field
Read More
UCSF Launches SUGAR Clinical Trial Study to Compare Livongo’s Diabetes Management Program to Standard Diabetes Care
Applied Health Signals company Livongo Health, today announced the launch of the Study to Understand Gaining Access to Blood Glucose Records (SUGAR), or SUGAR study, a randomized controlled trial in collaboration with the University of California, San Francisco (UCSF). The aim of the clinical trial is to measure the impact of the Livongo for Diabetes program compared to the average standard of care approach to diabetes management utilizing a traditional Bluetooth glucose meter. SUGAR Study
Read More
Roche Integrates Insulin Data from Novo Nordisk with Diabetes Management Solutions
Roche has signed a development and collaboration agreement with Novo Nordisk, a leader in innovating the therapy of diabetes and obesity. Under the terms of the development and collaboration agreement, the partners will integrate insulin data from Novo Nordisk's connected pen to Roche's open ecosystem, synchronizing with its suite of digital diabetes management solutions including mySugr.People with diabetes spend an average of one hour per day on self-care and have to make up to 50 therapy
Read More
Livongo Health and Abbott Partner to Offer Continuous Glucose Monitoring Insights
Livongo Health, a consumer digital health company empowering people with chronic conditions to live better and healthier lives, today announced that it will be the first comprehensive offering for people with diabetes to integrate continuous glucose data from Abbott’s FreeStyle® Libre Pro System, a revolutionary continuous glucose monitoring (CGM) system for healthcare professionals.Through this integration collaboration, Livongo will offer, where appropriate and prescribed, the FreeStyle Libre
Read More
iGlucose Integrates with Validic’s Data Connectivity Platform to Simplify Diabetes Management
Smart Meter, LLC, makers of the iGlucose® Cellular Diabetes Care Solution, announced its integration with Validic, a healthcare data connectivity platform. The integration brings a simple, convenient and affordable diabetes management solution to people with diabetes, healthcare teams, and population management programs. The iGlucose solution, which uses cell-enabled technology to automatically transmit real-time blood glucose results, removes complex technology issues by automatically
Read More
Rimidi Raises $6.575M for Cloud-based Enterprise Solution for Diabetes Management
Rimidi, Inc.(formerly known as Rimidi Diabetes), an Atlanta-based digital health startup that provides software and clinical analytics for chronic disease management, announced it has raised $6.575 million in Series A-1 financing, which includes a strategic investment by Eli Lilly and Company, an investment from Turner Investments, and participation from existing investors Cox Enterprises, Village Capital, The Jump Fund, and JAMB Global. The company plans to use the funding round to fuel growth
Read More
Brook Lands $4M for AI-Powered Diabetes Assistant App, Partners With Independent Health
Brook, a Seattle-based personalized diabetes assistant app platform for personal empowerment and intelligent support has raised $4M in funding from a group of investors. In addition to the funding, the startup has inked a strategic partnership with Independent Health, a Western New York State health plan to provide enhanced resources to help its 380,000 members self-manage their care and make the best decisions about their health. The partnership builds on the 2017 pilot program with Independent
Read More
Glooko Unveils Web-based Diabetes Analytics Platform
Diabetes management provider Glooko has unveiled new version of the Glooko Web Application (Population Tracker) that includes streamlined navigation and a large array of diabetes analytics, charts and graphs. The new web application version, which will now be rolled out in the U.S. and Canada and continue with the first European phase later this year, includes support for IDC’s Ambulatory Glucose Profile (AGP), an important standard with clinicians.The new web application version, which will now
Read More